ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010